---
title: "Core Laboratories Shareholders Back Directors, Auditor and Pay"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286325760.md"
description: "Core Laboratories Inc. held its Annual Meeting of Shareholders on May 12, 2026, where shareholders re-elected directors Harvey Klingensmith and Curtis Anastasio, ratified KPMG LLP as the independent auditor for 2026, and supported the executive compensation philosophy. The latest analyst rating for CLB stock is a Sell with a price target of $11.50. Spark's AI Analyst rates CLB as Neutral, citing weak technicals and revenue decline, but improved leverage and solid margins. Core Laboratories provides services to the upstream energy industry, focusing on optimizing reservoir performance."
datetime: "2026-05-13T22:30:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286325760.md)
  - [en](https://longbridge.com/en/news/286325760.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286325760.md)
---

# Core Laboratories Shareholders Back Directors, Auditor and Pay

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The latest announcement is out from Core Laboratories ( (CLB) ).

Core Laboratories Inc. held its Annual Meeting of Shareholders on May 12, 2026, in Houston, Texas, where investors considered director elections, auditor ratification, and executive compensation matters. Shareholders re-elected Class I directors Harvey Klingensmith and Curtis Anastasio to terms running until the 2029 annual meeting, maintaining continuity on the board.

Investors also approved the ratification of KPMG LLP as the company’s independent registered public accountant for the fiscal year ending December 31, 2026. In addition, shareholders supported, on an advisory basis, the company’s compensation philosophy and the pay packages of its named executive officers, signaling broad backing for Core Laboratories’ governance and leadership structure.

The most recent analyst rating on (CLB) stock is a Sell with a $11.50 price target. To see the full list of analyst forecasts on Core Laboratories stock, see the CLB Stock Forecast page.

**Spark’s Take on CLB Stock**

According to Spark, TipRanks’ AI Analyst, CLB is a Neutral.

The score is held back most by weak technicals (price below major moving averages and negative MACD) and a recent material revenue decline with only moderate cash conversion. These are partially offset by improved leverage, still-solid underlying margins, and earnings-call guidance pointing to modest sequential improvement alongside continued shareholder returns.

To see Spark’s full report on CLB stock, click here.

**More about Core Laboratories**

Core Laboratories Inc. is an oilfield services company that provides reservoir description, production enhancement, and related technologies to the upstream energy industry. The company focuses on helping oil and gas producers optimize reservoir performance and recovery, serving a global client base across major hydrocarbon-producing regions.

**Average Trading Volume:** 428,730

**Technical Sentiment Signal:** Strong Sell

**Current Market Cap:** $607.6M

See more insights into CLB stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [CLB.US](https://longbridge.com/en/quote/CLB.US.md)

## Related News & Research

- [CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE | CLB Stock News](https://longbridge.com/en/news/280215130.md)
- [Core Labs cuts Q1 guidance, citing impact of Middle East war](https://longbridge.com/en/news/280221703.md)
- [Is AI a bubble? It’s starting to get soapy](https://longbridge.com/en/news/286937439.md)
- [Legendary investor Jeremy Grantham says AI is the only thing that's prevented a recession and a market crash](https://longbridge.com/en/news/286934529.md)
- [Comcast to Participate in Evercore Investor Conference | CMCSA Stock News](https://longbridge.com/en/news/286951761.md)